Disclosure of payments to Healthcare Professionals and Healthcare Organisations
We are committed to the highest standards of conduct in all of our operations, including how we partner with physicians and medical institutions.
We believe in working transparently with the healthcare professionals and healthcare organisations that help us to develop innovative treatments that improve people’s health and wellbeing. In Europe we have many years of experience in collaborating with healthcare professionals on both early scientific research and within clinical trial programmes.
We believe in fair reimbursement to healthcare professionals and healthcare organisations for their time and expertise and are committed to ensuring the transparency of our relationships with them. Across Europe, the pharmaceutical industry discloses payments to health professionals and healthcare organisations at an individual level. Within the UK, together with other ABPI member companies, we are declaring the amount paid to individual healthcare professionals, or an aggregate payment which includes the total figure paid to healthcare professionals, plus the number of healthcare professionals who received payments and individual payments to healthcare organisations. In addition we are declaring payments made to healthcare professionals and healthcare organisations in the Netherlands and Denmark. Payments to healthcare professionals and healthcare organisations in Sweden, Norway, Switzerland and Finland are declared below.
There are no payments to disclose for 2022.